Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.

OBJECTIVE Our purpose was to estimate the annual risk of death in the United States from cardiovascular disease attributable to low-dose combination oral contraceptives. STUDY DESIGN Estimates of the risk of death from cardiovascular disease attributable to low-dose oral contraceptives were modeled on data from studies published through 1997 and from age-specific mortality rates in the United States for 1993 and 1994. RESULTS Attributable risk of death from cardiovascular disease resulting from oral contraceptive use is 0.06 and 3.0 per 100,000 nonsmokers 15 to 34 years of age and 35 to 44 years of age, respectively. In smokers this risk increases, respectively, to 1.73 and 19.4 per 100,000 users in these 2 age groups; however, 97% and 85% of this risk is due to the combined effects of smoking and using oral contraceptives. The attributable risk of death from cardiovascular disease in nonsmoking oral contraceptive users is lower than the risk of death from pregnancy in nonusers of oral contraceptives at all ages; however, among smoking oral contraceptive users more than 35 years of age, the excess risk of death from oral contraceptives is higher than the risk of death from pregnancy. CONCLUSION There is virtually no excess attributable risk of death from cardiovascular disease related to oral contraceptive use in young women. However, smokers more than 35 years of age should use a nonestrogen contraceptive.

[1]  O. Lidegaard.  Oral contraceptives and venous thromboembolism: an epidemiological review. , 1996, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[2]  P. Croft,et al.  Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. , 1989, BMJ.

[3]  D. Mant,et al.  Oral contraceptives and venous thromboembolism: findings in a large prospective study. , 1986, British medical journal.

[4]  H. Lawson,et al.  Ectopic pregnancy surveillance, United States, 1970-1987. , 1990, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[5]  P. Stolley,et al.  Thrombosis with low-estrogen oral contraceptives. , 1975, American journal of epidemiology.

[6]  M. Marmot,et al.  Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study , 1997, The Lancet.

[7]  A. Stergachis,et al.  Oral Contraceptives and Nonfatal Vascular Disease , 1985, Obstetrics and gynecology.

[8]  J. Shelton,et al.  Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. , 1997, Contraception.

[9]  M. Vessey,et al.  Oral contraceptives and stroke: findings in a large prospective study. , 1984, British medical journal.

[10]  D. Petitti,et al.  Myocardial Infarction in Users of Low‐Dose Oral Contraceptives , 1996, Obstetrics and gynecology.

[11]  J. Vandenbroucke,et al.  Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen , 1995, The Lancet.

[12]  M. Thorogood,et al.  Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case‐control study , 1991, British journal of obstetrics and gynaecology.

[13]  S. Harlap,et al.  Preventing pregnancy protecting health: a new look at birth control choices in the United States. , 1991 .

[14]  Gerald van Belle,et al.  Subarachnoid Hemorrhage and Hormonal Factors in Women: A Population-Based Case-Control Study , 1994, Annals of Internal Medicine.

[15]  M. Thorogood,et al.  Fatal stroke and use of oral contraceptives: findings from a case-control study. , 1992, American journal of epidemiology.

[16]  M. Thorogood,et al.  Risk factors for fatal venous thromboembolism in young women: a case-control study. , 1992, International journal of epidemiology.

[17]  H. Ory.  Mortality associated with fertility and fertility control: 1983. , 1983, Family planning perspectives.

[18]  H. Jick,et al.  Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components , 1995, The Lancet.

[19]  S. Shapiro,et al.  Oral contraceptive use and the risk of myocardial infarction. , 1990, American journal of epidemiology.

[20]  C. Wharton,et al.  Lower-dose pills. , 1988 .

[21]  H. Jick,et al.  Risk of acute myocardial infarction and low-dose combined oral contraceptives , 1996, The Lancet.

[22]  Daniel L. McGee,et al.  Obesity in peoples of the African diaspora. , 1996, Ciba Foundation symposium.

[23]  Stadel Bv.  Oral contraceptives and cardiovascular disease. (Second of two parts). , 1981 .

[24]  M. Marmot,et al.  Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case‐control study , 1996 .

[25]  B. Stadel.  Oral contraceptives and cardiovascular disease (first of two parts). , 1981, The New England journal of medicine.

[26]  S. Sidney,et al.  Stroke in users of low-dose oral contraceptives. , 1996, The New England journal of medicine.

[27]  I. Figa-talamanca,et al.  Correcting spontaneous abortion rates for the presence of induced abortion. , 1988, American journal of public health.

[28]  P. Croft,et al.  Oral Contraception and Stroke Evidence From the Royal College of General Practitioners' Oral Contraception Study , 1994, Stroke.

[29]  M. Marmot,et al.  Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study , 1996, The Lancet.

[30]  S. Shapiro,et al.  Venous Thromboembolism in Relation to Oral Contraceptive Use , 1987, Obstetrics and gynecology.

[31]  C. la Vecchia,et al.  Oral contraceptive use and risk of myocardial infarction: an Italian case-control study. , 1994, Journal of epidemiology and community health.

[32]  M. Thorogood,et al.  ORAL CONTRACEPTION AND MYOCARDIAL INFARCTION REVISITED: THE EFFECTS OF NEW PREPARATIONS AND PRESCRIBING PATTERNS , 1981, British journal of obstetrics and gynaecology.

[33]  S Kreiner,et al.  Oral contraceptives and venous thromboembolism. A case-control study. , 1998, Contraception.

[34]  J. A. Martin,et al.  ADVANCE REPORT OF FINAL NATALITY STATISTIC, 1992 , 1994 .

[35]  World Health Organization Collaborative Study of Cardiov Contarception.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study , 1995, The Lancet.

[36]  R. Bonita.  Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. , 1986, Stroke.

[37]  Ø. Lidegaard,et al.  Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. , 1993, BMJ.

[38]  R. Rochat,et al.  Maternal Mortality in the United States: Report From the Maternal Mortality Collaborative , 1988, Obstetrics and gynecology.

[39]  W. Willett,et al.  A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases , 1988 .

[40]  C. la Vecchia,et al.  Risk factors for myocardial infarction in young women. , 1987, American journal of epidemiology.

[41]  M. Thorogood,et al.  An epidemiologic survey of cardiovascular disease in women taking oral contraceptives. , 1990, American journal of obstetrics and gynecology.

[42]  W. Spitzer,et al.  Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study , 1996, BMJ.

[43]  A. Amos,et al.  [Women and tobacco]. , 1990, Servir.

[44]  W. Spitzer,et al.  Third generation oral contraceptives and risk of myocardial infarction: an international case-control study , 1996 .

[45]  D. Petitti,et al.  Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease. , 1978, American journal of epidemiology.